Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

57.50
+0.02500.04%
Volume:99.42K
Turnover:5.70M
Market Cap:5.39B
PE:24.48
High:57.59
Open:57.29
Low:57.07
Close:57.47
52wk High:73.01
52wk Low:48.26
Shares:93.67M
Float Shares:58.75M
Volume Ratio:0.65
T/O Rate:0.17%
Dividend:1.44
Dividend Rate:2.50%
EPS(TTM):2.35
EPS(LYR):2.62
ROE:8.76%
ROA:5.15%
PB:2.08
PE(LYR):21.94

Loading ...

Cognition Therapeutics Advances Zervimesine Toward Late-Stage DLB Trial

TIPRANKS
·
May 21

Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis

GlobeNewswire
·
May 21

Dolby SVP Shriram Revankar disposes 7,329 shares worth $401,901.09

Reuters
·
May 20

Dolby CEO Yeaman presents at William Blair Growth Stock Conference

Reuters
·
May 20

Boris Peaker Reiterates Buy on Neflamapimod Developer, Backs $20 Price Target on Pivotal DLB Phase III and Broad 2026 Clinical Catalysts

TIPRANKS
·
May 19

Press Release: Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dow Jones
·
May 14

Is Dolby (DLB) Using Buybacks And Dividends To Quietly Redefine Its Premium Audio Strategy?

Simply Wall St.
·
May 11

Press Release: Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update

Dow Jones
·
May 08

Dolby SVP John Couling sells Class A shares worth $720,349.45

Reuters
·
May 07

Is Dolby (DLB) Quietly Redefining Its Moat Through In‑Car Dolby Atmos And Steady Profitability?

Simply Wall St.
·
May 04

Analysts Offer Insights on Industrial Goods Companies: Dolby Laboratories (DLB) and Proto Labs (PRLB)

TIPRANKS
·
May 02

Dolby Laboratories Down Over 12%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk

Dow Jones
·
May 01

Rosenblatt Securities Keeps Their Buy Rating on Dolby Laboratories (DLB)

TIPRANKS
·
May 01

Dolby Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 01

Dolby Laboratories Posts Strong Q2 Results, Updates Outlook

TIPRANKS
·
May 01

Dolby FY26 Q2 net income rises 3.4% to USD 95 million; revenue climbs to USD 396 million

Reuters
·
May 01

Stock Track | Dolby Laboratories Plunges 6.69% After Hours on Disappointing Q3 Revenue Guidance

Stock Track
·
May 01

Entertainment firm Dolby Laboratories beats Q2 revenue expectations

Reuters
·
May 01

BRIEF-Dolby Laboratories Q2 Revenue USD 396 Million Vs. IBES Estimate USD 385.8 Million

Reuters
·
May 01

Dolby Laboratories Outlook Q3 Adjusted EPS USD 0.56-0.71

THOMSON REUTERS
·
May 01